The Controller General of Patents has invited comments on new draft patent application guidelines. These are aimed at improving patenting procedures for pharmaceutical and biotech inventions.
CGPDTM Seeks Feedback on Pharma and Biotech Patent Guidelines
The Controller General of Patents, Designs and Trademarks (CGPDTM) has released new draft guidelines for the examination of patent applications related to pharmaceutical and biotechnology inventions. These guidelines are part of an initiative to streamline and enhance procedures within the healthcare sector.
Stakeholders are encouraged to submit their comments and suggestions by the specified deadline, reflecting the CGPDTM's commitment to inclusive policy-making. The draft guidelines aim to address shortcomings in current practices, particularly in a rapidly evolving field that significantly impacts public health.
Practitioners in the life sciences sector should pay close attention to these developments. The feedback process presents an opportunity to influence the final guidelines and ensure they robustly support innovation while adhering to legal standards.
Citations
- Draft Guidelines by CGPDTM (2026)
